Two Sigma Advisers LP Takes $725,000 Position in Aspen Aerogels, Inc. (NYSE:ASPN)

Two Sigma Advisers LP purchased a new position in Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 61,000 shares of the construction company's stock, valued at approximately $725,000. Two Sigma Advisers LP owned 0.07% of Aspen Aerogels at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in the company. Two Sigma Investments LP boosted its stake in Aspen Aerogels by 637.9% during the fourth quarter. Two Sigma Investments LP now owns 592,765 shares of the construction company's stock worth $7,042,000 after buying an additional 512,439 shares during the period. Toronto Dominion Bank purchased a new position in shares of Aspen Aerogels in the 4th quarter worth approximately $266,000. Sandia Investment Management LP acquired a new position in Aspen Aerogels during the 4th quarter valued at about $89,000. Sherbrooke Park Advisers LLC purchased a new position in shares of Aspen Aerogels in the fourth quarter worth $202,000. Finally, Sora Investors LLC lifted its stake in shares of Aspen Aerogels by 289.8% during the fourth quarter. Sora Investors LLC now owns 487,245 shares of the construction company's stock worth $5,788,000 after buying an additional 362,245 shares during the period. Hedge funds and other institutional investors own 97.64% of the company's stock.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on the stock. Wall Street Zen raised Aspen Aerogels to a "sell" rating in a research report on Wednesday, February 19th. B. Riley dropped their price target on Aspen Aerogels from $35.00 to $22.00 and set a "buy" rating on the stock in a research note on Wednesday, February 19th. Craig Hallum cut their price objective on Aspen Aerogels from $21.00 to $18.00 and set a "buy" rating on the stock in a report on Friday, February 14th. TD Cowen upgraded Aspen Aerogels to a "strong-buy" rating in a research note on Tuesday, March 11th. Finally, Canaccord Genuity Group dropped their target price on Aspen Aerogels from $20.00 to $15.00 and set a "buy" rating on the stock in a research report on Friday, February 14th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $18.44.

Aspen Aerogels Stock Performance

Shares of ASPN traded up $0.25 during mid-day trading on Friday, reaching $6.04. The company had a trading volume of 1,263,857 shares, compared to its average volume of 2,009,711. The stock has a market capitalization of $495.91 million, a P/E ratio of 37.75 and a beta of 2.72. Aspen Aerogels, Inc. has a 52-week low of $4.16 and a 52-week high of $33.15. The stock has a 50 day moving average of $5.63 and a two-hundred day moving average of $9.11. The company has a quick ratio of 2.48, a current ratio of 2.93 and a debt-to-equity ratio of 0.27.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last announced its quarterly earnings results on Thursday, May 8th. The construction company reported ($0.06) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.07) by $0.01. Aspen Aerogels had a return on equity of 7.49% and a net margin of 2.95%. The company had revenue of $78.72 million during the quarter, compared to the consensus estimate of $82.75 million. During the same period in the previous year, the company posted ($0.02) earnings per share. Aspen Aerogels's revenue for the quarter was down 16.7% on a year-over-year basis. On average, analysts expect that Aspen Aerogels, Inc. will post 0.17 earnings per share for the current year.

Insider Activity at Aspen Aerogels

In other Aspen Aerogels news, CEO Donald R. Young purchased 20,000 shares of the business's stock in a transaction that occurred on Monday, May 12th. The stock was purchased at an average price of $5.35 per share, for a total transaction of $107,000.00. Following the purchase, the chief executive officer now directly owns 550,856 shares in the company, valued at approximately $2,947,079.60. This trade represents a 3.77% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 4.30% of the company's stock.

Aspen Aerogels Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.